| Normal values n = 41 | Reactive cytopenias n = 35 | MDS <5% BM blasts n = 42 | MDS >5% BM blasts n = 12 | p |
---|---|---|---|---|---|
Granulocytic series | Â | Â | Â | Â | Â |
SSC | 521 (396–658) | 534 (340–628) | 394 (236–619) | 462 (319–648) | <0.0001 |
CD45 MFI | 138-577 | 265 (107–683) | 216 (34–770) | 270 (89–551) | 0.02 |
Asynchronous shift to the left | Â | 7 (21%) | 11 (26%) | 6 (46%) | 0.12 |
Monocytic series | Â | Â | Â | Â | Â |
SSC | 253 (196–399) | 237 (149–390) | 233 (66–399) | 203 (184–322) | 0.01 |
% monocytes | 0.8-3.6 | 3.0 (0.7 - 8.8) | 3.7 (0.2 - 18) | 3.3 (0.1 - 21) | 0.22 |
% CD16+ monocytes | <0.48 | 0.3 (0.1 - 3.4) | 0.4 (0.02 - 10) | 0.9 (0.05 - 4) | 0.003 |
Cells in the blast gate | Â | Â | Â | Â | Â |
BM % blasts (cytology) | Â | 1.0 (0.5 - 4.0) | 1.0 (0.5 - 5) | 12 (7.7 - 18) | Â |
% CD34+ cells | <1.59 | 0.6 (0.02-2.1) | 1.0 (0.02- 5.1) | 3.6 (0.2 - 28) | <0.0001 |
% B cell precursors/total cells | >0.05 (0.04-0.53) | 0.06 (0–0.7) | 0.06 (0–0.7) | 0.01 (0.01 - 0.14) | <0.0001 |
%CD34+/CD13+/CD117+ | <0.62 | 0.3 (0.01-0.8) | 0.5 (0.01-4.2) | 1.4 (0–24.1) | 0.001 |
% CD34+/CD7+ | <0.08 | 0.05 (0–0.09) | 0.04 (0–0.7) | 0.13 (0.04-26) | <0.0001 |
% CD34+/CD56+ | <0.05 | 0.01 (0–0.09) | 0.03 (0–1.9) | 0.13 (0.02-27) | <0.0001 |
Total abnormalities | 0 (0–2) | 2 (0–5) | 7 (3–13) | 9 (6–16) | <0.0001 |